Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
98M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
18.4M
-
Shares change
-
-705K
-
Total reported value, excl. options
-
$40.2M
-
Value change
-
-$2.08M
-
Put/Call ratio
-
12.18
-
Number of buys
-
20
-
Number of sells
-
-12
-
Price
-
$2.19
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q4 2022
43 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q4 2022.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.4M shares
of 98M outstanding shares and own 18.73% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (5.23M shares), FMR LLC (4.35M shares), Alyeska Investment Group, L.P. (1.38M shares), Tikvah Management LLC (1.35M shares), VR Adviser, LLC (1.17M shares), VANGUARD GROUP INC (1.14M shares), Walleye Capital LLC (750K shares), Telemetry Investments, L.L.C. (624K shares), CITIGROUP INC (428K shares), and BlackRock Inc. (269K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.